Showing results (31-40 of 70) with videos related to
Sort By:
Pageof 7
Zeitschrift Fur Rheumatologie|September 4, 2025
[Long-term follow up of efficiency and safety of CD19-CAR T-cell treatment of systemic lupus erythematosus]Jule Taubmann, Sebastian Böltz, Melanie Hagen, et al.BMC Immunology|March 16, 2025
Effect of delayed isolation of peripheral blood mononuclear cells on cell viability and functionalitySarah Lehle, Simon Völkl, Katharina Seitz, et al.Cancer Research|July 2, 2020
Palmitoylated Proteins on AML-Derived Extracellular Vesicles Promote Myeloid-Derived Suppressor Cell Differentiation via TLR2/Akt/mTOR SignalingSehmus Tohumeken, Rebecca Baur, Martin Böttcher, et al.Hemasphere|August 14, 2025
3D Tumor microenvironment interaction reveals AP-1 complex regulation and contact-mediated reprogramming of bone marrow stromal cells in chronic lymphocytic leukemiaJana Lindacher, Anne Hartebrodt, Janin Dingfelder, et al.Frontiers in Immunology|April 10, 2026
Universal high-sensitivity CAR T-cell monitoring by targeting linker sequencesNora Rebecca Schwingen, Lina Meretuk, Michael Aigner, et al.Journal for Immunotherapy of Cancer|May 1, 2021
Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axisMartin Böttcher, Heiko Bruns, Simon Völkl, et al.Hemasphere|December 10, 2025
Functional differences between CLL- and ALL-derived CAR T cells in a 3D tumor microenvironment highlight CXCR4 and IL-10 as potential modulatory targetsJanin Dingfelder, Michael Aigner, Jana Lindacher, et al.Journal for Immunotherapy of Cancer|March 10, 2023
Accumulation of T-cell-suppressive PD-L1high extracellular vesicles is associated with GvHD and might impact GvL efficacyRebecca Baur, Franziska Karl, Romy Böttcher-Loschinski, et al.Haematologica|February 13, 2025
One CHiP to rule them all? Mechanistic insight into carfilzomib-induced lung injury with neutrophil extracellular trap formation following cellular immunotherapyJulia Katharina Scholz, Lena Stabel, Nora Rebecca Schwingen, et al.Cancers|November 13, 2021
Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular SubtypesRamona Erber, Sareetha Kailayangiri, Hanna Huebner, et al.Pageof 7